| 4863 |
Centers for Disease Control and Prevention |
Html |
en |
2009 H1N1: Overview of a Pandemic - 508 Accessible version |
null |
| H1N1 virus | 0.578075 |
| website | 0.36414 |
| stand-alone Web document | 0.729758 |
| CDC Seasonal Flu | 0.865237 |
| information | 0.361508 |
| reference purposes | 0.542622 |
|
| page | 0.337161 |
| PowerPoint presentation | 0.533989 |
| pandemic | 0.4653 |
| human flu virus | 0.931057 |
| Section 508-accessible version | 0.69968 |
|
CLICK HERE |
| 5246 |
Centers for Disease Control and Prevention |
Html |
en |
Identifying Metabolic Syndrome in African American Children Using Fasting HOMA-IR in Place of Glucose |
null |
| blood glucose | 0.925362 |
| blood pressure | 0.373498 |
| glucose concentration | 0.415479 |
| fasting blood glucose | 0.215745 |
| waist circumference | 0.356488 |
| MetS components | 0.225024 |
| HOMA-IR | 0.336656 |
| MetS | 0.541346 |
|
| blood glucose concentration | 0.34047 |
| diastolic blood pressure | 0.266522 |
| high-density lipoprotein cholesterol | 0.229034 |
| cutoff | 0.200191 |
| African American children | 0.741142 |
| insulin resistance | 0.375877 |
| MetS component | 0.245142 |
|
CLICK HERE |
| 7756 |
Centers for Disease Control and Prevention |
Html |
en |
Update: Influenza Activity - United States, September30-November 24, 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| ILI activity ††| 0.532459 |
| influenza §§ | 0.60375 |
| Influenza Div | 0.597428 |
| influenza A viruses | 0.663476 |
| influenza vaccine viruses | 0.662104 |
| Hemisphere influenza vaccine | 0.633654 |
| New York City | 0.538256 |
| outpatient visits | 0.499186 |
| influenza antiviral medications | 0.621406 |
| ILI activity level | 0.532099 |
| moderate ILI activity | 0.531087 |
| Influenza virus–positive tests | 0.635821 |
| influenza A virus | 0.628546 |
| respiratory specimens | 0.525557 |
| influenza vaccine | 0.668407 |
| World Health Organization | 0.595993 |
| influenza activity | 0.803132 |
| influenza surveillance systems | 0.632878 |
| U.S. Outpatient ILI | 0.529407 |
| minimal ILI activity | 0.530367 |
| Sporadic influenza activity | 0.64485 |
| influenza virus circulation | 0.607422 |
| ILI activity | 0.669392 |
| influenza b viruses | 0.770578 |
|
| laboratory-confirmed influenza cases | 0.604824 |
| influenza | 0.959998 |
| CDC influenza surveillance | 0.68373 |
| United States | 0.813937 |
| novel influenza | 0.645725 |
| influenza-related pediatric deaths | 0.541865 |
| low ILI activity | 0.532437 |
| influenza complications*** | 0.593838 |
| influenza B component | 0.609318 |
| high ILI activity | 0.532585 |
| influenza A vaccine | 0.613312 |
| U.S. Virgin Islands | 0.585928 |
| National Influenza Vaccination | 0.659909 |
| recent laboratory evidence | 0.501799 |
| Cities Mortality Reporting | 0.575165 |
| laboratory-confirmed influenza | 0.605941 |
| Influenza surveillance reports | 0.626352 |
| overall influenza activity | 0.634325 |
| influenza season | 0.746101 |
| U.S. influenza activity* | 0.659326 |
| Enteric Virus Surveillance | 0.579177 |
| Illness Surveillance Network | 0.524053 |
| influenza seasons | 0.599302 |
| influenza viruses | 0.847001 |
|
CLICK HERE |
| 8091 |
Centers for Disease Control and Prevention |
Html |
en |
Newsroom - CDC Advisory -CDC's Advisory Committee on Immunization Practices Meeting |
[Title] |
| Centers | 0.436978 |
| free vaccine | 0.704935 |
| RSVP attendance | 0.653078 |
| routine discussion | 0.620634 |
| navigation Skip | 0.84601 |
| Haemophilus influenzae | 0.688374 |
| pertussis | 0.458094 |
| Prevention | 0.436899 |
| Immunization Practices | 0.884896 |
| Advisory Committee | 0.817263 |
| Need | 0.442036 |
| Clifton Road NE | 0.837514 |
| Disease Control | 0.632154 |
| immune-compromising conditions | 0.606926 |
| ACIP meeting | 0.711477 |
| page options | 0.652594 |
| Atlanta | 0.468158 |
| influenza vaccine recommendations | 0.886746 |
| U.S. DEPARTMENT | 0.605738 |
| contact | 0.43299 |
|
| http://www.cdc.gov/vaccines/acip/index.html | 0.435784 |
| visit http://www.cdc.gov/about/resources/visitGuide.htm#direction | 0.621822 |
| flu season | 0.608423 |
| pneumococcal conjugate vaccine | 0.907985 |
| PCV13 | 0.433111 |
| list Skip | 0.850791 |
| Tom Harkin Global | 0.849025 |
| Children program | 0.602482 |
| Hib vaccine | 0.794048 |
| media activities | 0.605767 |
| agency updates | 0.612181 |
| pneumococcal infection | 0.613212 |
| agenda | 0.488295 |
| workgroup updates | 0.623555 |
| content Skip | 0.849086 |
| directions | 0.435944 |
| Auditorium | 0.452976 |
| HUMAN SERVICES | 0.605255 |
| information | 0.436311 |
|
CLICK HERE |
| 9766 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Salmonella Typhimurium InfectionsAssociated with a Community College Microbiology Laboratory -Maine, 2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.816427 |
| microbiology class | 0.834438 |
| stool specimens | 0.803905 |
| Human Services | 0.881236 |
| teaching level | 0.803372 |
| assistive technology | 0.813555 |
| low response rate | 0.880529 |
| site visit | 0.868569 |
| case interviews | 0.804432 |
| U.S. Department | 0.880936 |
| MMWR HTML versions | 0.876063 |
| Disease Control | 0.813104 |
| PFGE analysis | 0.808308 |
| electronic PDF version | 0.87573 |
| hospital laboratories | 0.804231 |
| Salmonella Typhimurium outbreak | 0.973174 |
| PFGE pattern | 0.805546 |
| e-mail survey | 0.811388 |
| microbiology laboratory course | 0.949178 |
| personal protective equipment | 0.87752 |
| Environmental Testing Laboratory | 0.931183 |
| Contact GPO | 0.808019 |
| Epidemiologic interviews | 0.8099 |
| clinical Salmonella | 0.844364 |
|
| original paper copy | 0.869466 |
| laboratory class | 0.922899 |
| Southern Maine | 0.805431 |
| Maine Center | 0.826739 |
| potential contamination hazards | 0.873321 |
| pulsed field gel | 0.891129 |
| original MMWR paper | 0.883047 |
| U.S. Government Printing | 0.876275 |
| PFGE results | 0.814932 |
| college laboratory | 0.842664 |
| Human Svcs | 0.909064 |
| community college | 0.908047 |
| Maine Dept | 0.886299 |
| wear gloves | 0.824329 |
| subject line | 0.813786 |
| clinical isolates | 0.825983 |
| laboratory practices survey | 0.926145 |
| biologic safety guidelines | 0.883915 |
| national outbreak investigation | 0.923438 |
| laboratory coats | 0.828436 |
| Salmonella culture | 0.831971 |
| common exposure | 0.810774 |
| laboratory practices | 0.976496 |
| teaching microbiology laboratories | 0.91995 |
|
CLICK HERE |
| 11149 |
Centers for Disease Control and Prevention |
Html |
en |
B Virus | Resources and Publications | Herpes B | CDC |
Journal articles and publications about B virus and B virus infection. |
| public settings | 0.537687 |
| infectious disease issues | 0.480099 |
| herpesvirus B-seropositive macaques | 0.555841 |
| CDC. Notice | 0.477008 |
| CDC National Institute | 0.488123 |
| Section VIII—Agent Summary | 0.480243 |
| reports B virus | 0.486023 |
| Appl Occup Environ | 0.467717 |
| Infect Dis | 0.902955 |
| Epidemiologic notes | 0.479573 |
| State Public Health | 0.656326 |
| Herpesvirus simiae | 0.518985 |
| biomedical laboratories | 0.510377 |
| L. Cercopithecine herpesvirus | 0.558832 |
| ocular exposure | 0.521318 |
| reports B-virus infection | 0.489282 |
| Disease Control | 0.516055 |
| Working Group | 0.4742 |
| Engel GA | 0.467814 |
| Clin Infect Dis | 0.703537 |
| monkey B virus | 0.528933 |
| U.S. Public Health | 0.561178 |
| M. Fatal Infection | 0.477533 |
| National Institutes | 0.51479 |
|
| Fatal Cercopithecine herpesvirus | 0.567249 |
| venereal B virus | 0.479719 |
| occupational safety | 0.557786 |
| Chapman LE | 0.517858 |
| Public Health Veterinarians | 0.656169 |
| Human herpesvirus | 0.506575 |
| nonhuman primates | 0.477421 |
| National Research Council | 0.475511 |
| Hilliard JK | 0.671257 |
| Health Service guideline | 0.49005 |
| infectious Cercopithecine herpesvirus | 0.546547 |
| National Association | 0.540051 |
| J. B virus | 0.483794 |
| MMWR Recomm Rep | 0.743975 |
| Public Health Service | 0.561162 |
| pet macaque monkeys | 0.468904 |
| serial online | 0.582944 |
| Stewart JA | 0.524705 |
| et al | 0.602538 |
| Weigler BJ | 0.469783 |
| Cercopithecine herpesvirus | 0.652666 |
| Government Printing Office. | 0.631656 |
| Davenport DS | 0.571695 |
|
CLICK HERE |
| 11362 |
Centers for Disease Control and Prevention |
Html |
en |
Tools for Protecting Healthcare Personnel - HAI |
null |
| training healthcare personnel | 0.459529 |
| HICPAC Publications page | 0.379607 |
| current CDC guidance | 0.381456 |
| HIV-infected blood MMWR | 0.403685 |
| CDC Sharps Safety | 0.395744 |
| Health Promotion Update | 0.364661 |
| Healthcare Settings NIOSH | 0.433732 |
| healthcare infection control | 0.478697 |
| Occupational Blood Exposures | 0.588637 |
| personal protective equipment | 0.715078 |
| Invasive Procedures MMWR | 0.397473 |
| Preventing Percutaneous Injuries | 0.508864 |
| healthcare epidemiologists | 0.373511 |
| postexposure prophylaxis | 0.799098 |
| acute-care hospital settings | 0.371578 |
| human immunodeficiency virus | 0.907375 |
| Postexposure Prophylaxis Infection | 0.531491 |
| bloodborne pathogens | 0.490321 |
| Healthcare settings MMWR | 0.466727 |
| healthcare personnel | 0.631102 |
| healthcare providers | 0.369415 |
| Hepatitis B Virus | 0.431211 |
| Clinicians Post-Exposure Prophylaxis | 0.432017 |
| Appendix B. Management | 0.391378 |
| infection control | 0.742266 |
|
| HIV testing services | 0.414676 |
| Bloodborne Pathogens MMWR | 0.42949 |
| HIV Postexposure Prophylaxis | 0.557119 |
| protective equipment PPE | 0.417971 |
| Ebola Virus Disease | 0.439641 |
| occupational HIV exposure | 0.620004 |
| Injuries Among Healthcare | 0.379813 |
| Health Service Guidelines | 0.65792 |
| Postexposure Prophylaxis MMWR | 0.539142 |
| infection control programs | 0.432286 |
| HIV transmission | 0.367964 |
| U.S. Public Health | 0.49618 |
| Hospital Epidemiology Vol. | 0.369738 |
| occupational exposures | 0.593338 |
| Healthcare Personnel Need | 0.447976 |
| Health Omnibus Programs | 0.371508 |
| Healthcare Workers | 0.382139 |
| Appendix C. Basic | 0.375231 |
| infection control staff | 0.433037 |
| A. Practice Recommendations | 0.386598 |
| Public Health Service | 0.660893 |
| Blood Exposures MMWR | 0.454179 |
| healthcare work environment | 0.460543 |
| healthcare settings | 0.561254 |
|
CLICK HERE |
| 11626 |
Centers for Disease Control and Prevention |
Html |
null |
Appendix: Additional Results and Technical Notes for the EbolaResponse Modeling Tool |
Numbers of Ebola virus disease cases (hereafter referred to as Ebola) and daily number of beds in use in Liberia and Sierra Leone alone (Figure 1) and in Liberia and Sierra Leone combined (Figure 2) were estimated using the EbolaResponse modeling tool. The outcome of potential interventions on number of cases and beds in use in the two countries combined was simulated (Figure 3). |
|
|
CLICK HERE |
| 13995 |
Centers for Disease Control and Prevention |
Image |
null |
Unique Factors Place Youth at Risk for STIs |
null |
|
|
CLICK HERE |
| 14453 |
Centers for Disease Control and Prevention |
Html |
en |
NIHSeniorHealth: What is Skin Cancer? |
NIHSeniorHealth.gov, NIH Senior Health |
| heat | 0.241109 |
| skin cancer | 0.963763 |
| common type | 0.411014 |
| infection | 0.245492 |
| Nonmelanoma skin cancer | 0.530596 |
| nearby tissues | 0.402143 |
| skin cancers | 0.656293 |
| percent | 0.244078 |
| squamous cells | 0.450946 |
| Kaposi sarcoma | 0.416881 |
| cell skin cancers | 0.588271 |
| melanocytes | 0.267366 |
| Squamous cell | 0.428242 |
| nonmelanoma skin cancers | 0.58941 |
|
| layers | 0.249372 |
| body temperature | 0.412353 |
| injury | 0.241024 |
| Rare types | 0.376454 |
| deaths | 0.241882 |
| epidermis | 0.262879 |
| Merkel cell carcinoma | 0.560069 |
| different types | 0.38718 |
| stores water | 0.424187 |
| sunlight | 0.328555 |
| outer layer | 0.414239 |
| parts | 0.269253 |
| skin lymphoma | 0.389555 |
|
CLICK HERE |